We are live on ! Find out more
AVNS icon

Avanos Medical

318 hedge funds and large institutions have $1.9B invested in Avanos Medical in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 82 increasing their positions, 103 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more call options, than puts

Call options by funds: $2.24M | Put options by funds: $1.79M

12% more capital invested

Capital invested by funds: $1.69B → $1.9B (+$208M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

3% less funds holding

Funds holding: 328318 (-10)

17% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 36

20% less repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 103

Holders
318
Holders Change
-10
Holders Change %
-3.05%
% of All Funds
7.93%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
30
Increased
82
Reduced
103
Closed
36
Calls
$2.24M
Puts
$1.79M
Net Calls
+$449K
Net Calls Change
+$1.4M
Name Holding Trade Value Shares
Change
Change in
Stake
ASRS
101
Arizona State Retirement System
Arizona
$1.19M +$291K +6,810 +35%
ANTB
102
AMG National Trust Bank
Colorado
$1.14M +$31.4K +737 +3%
Ohio Public Employees Retirement System (OPERS)
103
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.14M +$853K +19,984 +374%
Federated Hermes
104
Federated Hermes
Pennsylvania
$1.07M -$35.5K -832 -3%
BNP Paribas Financial Markets
105
BNP Paribas Financial Markets
France
$1.05M -$158K -3,692 -14%
MSA
106
Mason Street Advisors
Wisconsin
$1.05M +$18.2K +427 +2%
TD Asset Management
107
TD Asset Management
Ontario, Canada
$1.04M -$89.6K -2,100 -8%
SEI Investments
108
SEI Investments
Pennsylvania
$1.03M +$201K +4,707 +26%
Bessemer Group
109
Bessemer Group
New Jersey
$1.03M
Los Angeles Capital Management
110
Los Angeles Capital Management
California
$1.01M
Royal Bank of Canada
111
Royal Bank of Canada
Ontario, Canada
$1.01M +$213K +4,980 +29%
MHC
112
Meyer Handelman Company
New York
$962K -$297K -6,949 -25%
ADEF
113
Adams Diversified Equity Fund
Maryland
$959K -$34.1K -800 -4%
O
114
OppenheimerFunds
New York
$945K -$115K -2,696 -11%
MAM
115
Meeder Asset Management
Ohio
$941K +$3.54K +83 +0.4%
PG
116
Patten Group
Tennessee
$877K
First Trust Advisors
117
First Trust Advisors
Illinois
$864K -$34.5K -808 -4%
CSS
118
Cubist Systematic Strategies
Connecticut
$847K +$762K +17,867 +1,913%
HK
119
Horizon Kinetics
New York
$840K -$42.8K -1,002 -5%
State of New Jersey Common Pension Fund D
120
State of New Jersey Common Pension Fund D
New Jersey
$833K
AIP
121
Ameritas Investment Partners
Nebraska
$807K -$512 -12 -0.1%
SO
122
STRS Ohio
Ohio
$801K -$265K -6,200 -26%
SOMRS
123
State of Michigan Retirement System
Michigan
$793K -$68.3K -1,600 -8%
OAM
124
Oppenheimer Asset Management
New York
$785K +$113K +2,652 +18%
OPERF
125
Oregon Public Employees Retirement Fund
Oregon
$775K +$6.74K +158 +0.9%

AVNS Hedge Fund Activity: Q3 2017 in Review

318 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q3 2017, worth a combined $1.9B — up 12% from $1.69B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of AVNS and 30 opened new positions — a net loss of 6 holders — while 103 trimmed existing stakes and 82 added.

The largest buyer was Macquarie Group, opening a new position worth an estimated $18.1M. The largest seller was Citadel Advisors, exiting entirely with an estimated $34.1M sold.

  • 318 institutional investors held Avanos Medical (AVNS) as of Q3 2017, down from 328 in Q2 2017.
  • Funds reported $1.9B of Avanos Medical stock for Q3 2017, up 12% quarter-over-quarter.
  • 30 funds opened new Avanos Medical positions in Q3 2017 and 36 closed out, a net change of -6 holders.
  • The largest Avanos Medical buyer in Q3 2017 was Macquarie Group, an estimated $18.1M added.
  • The largest Avanos Medical seller in Q3 2017 was Citadel Advisors, an estimated $34.1M sold.

Based on aggregated 13F filings for Q3 2017.